Sysmex and Pinfeng Medical Forge Strategic Partnership to Launch Domestic Smart Laboratory Automation Line and High-Speed Clinical Chemistry Analyzers

In recent years, the localization of domestically produced high-speed clinical chemistry support systems and IVD automation lines has accelerated. An increasing number of Chinese companies have launched fully localized high-speed clinical chemistry analyzers and integrated automation lines, while foreign enterprises have adopted an increasingly open mindset, actively embracing domestically produced high-speed clinical chemistry analysis systems and automation lines.

Recently, Sysmex, a globally renowned IVD company, has entered into a strategic partnership with Pinnacles. Through Sysmex’s mature distribution network, this collaboration will bring Pinnacles’ Kunlun series of high-speed clinical chemistry analyzers and laboratory automation lines to market alongside Sysmex’s product portfolio. By leveraging their respective strengths and integrating resources, the two companies aim to optimize their product offerings and deepen cooperation in providing comprehensive solutions for clinical chemistry and immunoassay diagnostics. This initiative seeks to meet the strong clinical demand for high-speed clinical chemistry analyzers and for automated, intelligent testing and inspection systems.

Competition in China’s IVD market is becoming increasingly fierce, gradually entering a phase where domestic brands are coming to the fore. Against the backdrop of clinical demand and policies promoting import substitution and centralized procurement, high-throughput automated biochemistry analyzers and laboratory automation lines produced by Chinese manufacturers have emerged as new growth hotspots in the IVD sector.

Biochemistry, as a fundamental clinical test, has highly mature clinical applications and is already a red ocean market. High-speed biochemistry analyzers represent a blue ocean within this red ocean market.China is in a window of opportunity for upgrading from medium-speed to high-speed clinical chemistry analyzers.

High-speed biochemistry analyzers boast multiple advantages, including faster speed, efficient system operation, and precise results. As centralized procurement and cost-control measures continue to advance, the demand for high-speed biochemistry analyzers that meet the clinical need for cost reduction and efficiency improvement is rapidly increasing in hospitals at secondary level and above, creating substantial market opportunities for domestically produced high-speed biochemistry analyzers. Data shows that the compound annual growth rate (CAGR) of domestically produced high-speed biochemistry analyzers in China exceeds 10%.

China's IVD Total Laboratory Automation (TLA) Market Is Also Undergoing Significant Transformation.

Historically, the IVD automation line market in China has been dominated by foreign enterprises. Imported automation lines are all closed systems, which severely restricts hospitals’ ability to expand testing menus and control costs. There is an urgent clinical need for open automation lines compatible with instruments from different brands to fully integrate existing resources within clinical laboratories.

Domestic open automation lines are becoming the prevailing trend.Rapid Rise of Cost-Effective, Highly Compatible Domestic Automated Laboratory Lines, all sub-sectors of the IVD industry are aligning with automated laboratory assembly lines,Assembly line integration has become one of the key competitive factors among IVD companies, and collaborations between multinational corporations and domestic assembly lines are becoming increasingly common.. Domestic automated laboratory assembly lines have entered a golden period of development.

Ding Wei, founder of Pinnacles, judges thatThe rising wave of domestication for high-end, high-throughput biochemistry analyzers and laboratory automation lines will present new opportunities in the future.It is crucial to promote in-depth collaboration between foreign-invested enterprises and local companies. These trends have facilitated the current partnership between Sysmex and Pinnacles.

The collaboration between Sysmex and Pinnacles Medical is a typical example of partnerships between foreign enterprises and Chinese local companies in the field of high-speed clinical chemistry supporting analysis systems and automation lines for in vitro diagnostics (IVD). Peng Zuohui, Global Executive Director of Sysmex Corporation and CEO of Sysmex Medical Electronics (Shanghai) Co., Ltd., stated: “First, in the field of biochemistry and immunoassay testing, Sysmex lacks high-speed clinical chemistry analyzers. By introducing domestically produced high-speed clinical chemistry analysis systems and smart automation lines, and integrating them with Sysmex’s highly sensitive immunochemiluminescence detection systems, we can form an integrated biochemistry-immunology automation line to meet the demands of the domestic market for hospitals at Level II and above. Second, we have a long history of cooperation with Mr. Ding Wei, founder of Pinnacles Medical, establishing a strong foundation of trust; Mr. Ding possesses outstanding integration capabilities and execution skills. Third, the products have undergone repeated and rigorous performance evaluations by Sysmex and demonstrated excellent performance. Fourth, we value the Pinnacles Medical team’s industrialization experience and potential R&D capabilities, which ensure continuous product iteration and upgrades. Fifth, by combining the after-sales teams of both parties, we can provide customers with reliable after-sales support. Currently, the cooperation with Pinnacles Medical is progressing rapidly and smoothly, and we have jointly facilitated the installation and use of the products at multiple customer sites.”

IVD automation lines and high-speed biochemistry analyzers are becoming standard equipment in clinical laboratories. Key factors in evaluating high-speed biochemistry analyzers and IVD automation lines include cost-effectiveness, accuracy, efficiency, and the extent of domestic production. Particularly under the requirements for smart hospital development, the level of intelligence has become an important metric for assessing both.

Pinnacles' Kunlun Series ModularHigh-Speed Fully Automated Biochemistry AnalyzerThe KunLun c2800 system demonstrates significant advantages in terms of test menu, intelligence, quality, and pricing. It offers a comprehensive range of biochemical and specialized reagent assays, occupies only 2.3 m² of floor space, and delivers high efficiency. The system has been listed on major provincial procurement platforms across China. It achieved favorable winning bids in the volume-based procurement for liver function tests, providing more precise, stable, and cost-effective results. Additionally, its modular automation line offers excellent cost-performance ratio for scalability.

In addition, Pinnacles has launched the KunLun S-LASSmart Biochemical and Immunological Automation Line, comprising high-speed biochemistry and immunoassay modules, high-efficiency sample processing modules, and an intelligent sample management system,It has truly achieved full localization of all modules.The product features rapid sample processing and exceptional space efficiency. It has integrated software and hardware interfaces with analytical modules from mainstream IVD manufacturers both domestically and internationally, achieving multi-brand compatibility. This provides an ideal domestic automated assembly line solution for medical laboratories in healthcare institutions at all levels.

Sysmex is a globally renowned IVD company with over 70 branches in China, Europe, the Americas, and the Asia-Pacific region. Its products are available in more than 190 countries worldwide. Sysmex holds a leading global position in hematology analysis, coagulation analysis, and urine sediment analysis, while also strengthening its presence in clinical chemistry, immunodiagnostics, and point-of-care testing. The High-Sensitivity Chemiluminescence Immunoassay System—HISCL series—has been installed in over 1,500 hospitals, offering nearly 60 routine and specialized immunoassay tests.Supported by Pinnacles’ high-speed biochemistry analyzers and automation lines, Sysmex’s competitiveness in the biochemistry and immunology market will be further enhanced.

Yang Yu, Chairman of Sysmex Medical Electronics (Shanghai) Co., Ltd., stated: “In China, Sysmex is one of the earliest imported IVD brands to establish local manufacturing facilities. Sysmex Shanghai was established in 2000; Jinan Sysmex Medical Electronics Co., Ltd., founded in 1995, manufactures clinical laboratory analyzers and in vitro diagnostic reagents; and Sysmex Biotechnology (Wuxi) Co., Ltd., established in 2003, set up a development center in 2009 and primarily produces in vitro diagnostic reagents. Sysmex has always adhered to its original aspiration, upholding the same craftsmanship spirit as its Japanese headquarters. Through rigorous production protocols and extremely stringent quality control standards, Sysmex comprehensively ensures product quality and cost-effectiveness.”Today, the collaboration with Pinnacles Medical’s high-speed biochemistry and smart automation lines signifies that Sysmex has perfected its integrated solution for domestically produced biochemical and immunological automation lines, enabling better service to customers in the Chinese market.

Notably,Pinnacles’ vision extends beyond high-speed biochemistry analyzers or IVD assembly lines; it aims to create “unmanned” intelligent and smart laboratories through smart laboratory testing solutions.

Smart hospital development is a shared focus in the current healthcare sector. The National Health Commission of China has called for summarizing practical experiences in hospital informatization and establishing an integrated “triune” smart hospital system encompassing medical care, services, and management. As a crucial component of smart hospitals, smart laboratories are rapidly advancing alongside the broader wave of smart hospital construction.

Smart Laboratory Solutions enable more precise disease detection, higher efficiency, streamlined workflows, and improved experiences for both patients and healthcare providers. They represent the next major development focus for clinical laboratories following automation lines, as well as an emerging growth driver for enterprises.

AsLeader in Smart Laboratory DiagnosticsandPioneer of Unmanned Laboratories, Pinnacles has rapidly developed its proprietary smart laboratory holistic solution through the integration of resources and strategic deployment both within and beyond the industry. Building upon traditional pre-processing and assembly line products, it provides more efficient and intelligent high-value-added smart solutions, including full-process automation from sample to result, integrated information management, and clinical decision support. Meanwhile, Pinnacles is continuously enriching its smart laboratory testing ecosystem to create a more comprehensive and truly intelligent medical laboratory.

Ding Wei, Chairman of Pinnacles Medical, stated, “Precision medicine begins with precise diagnosis. With the Chinese IVD market growing at an annual rate of over 10%, there is vast room for development. The continuous advancement of centralized procurement, coupled with the market’s persistent demand for products that offer both high quality and cost-effectiveness, has ushered China’s IVD market into a new phase of reshuffling. First, smart laboratory testing is a key growth area; we are currently building ‘unmanned laboratories.’ Second, future industry leaders will rely on platform integration and extensive collaboration as their core strategy. The partnership between Pinnacles Medical and Sysmex is not merely a manufacturer-distributor relationship; rather, we are jointly building an ecosystem to contribute to the development of China’s IVD industry.”

Professor Li Yan, Clinical Medical Advisor at Pinnacles, stated, “Large hospitals process thousands of biochemical specimens daily, posing significant challenges to the efficiency and accuracy of test report issuance and driving the rapid adoption of automated solutions such as laboratory automation lines. The highly complementary partnership between Pinnacles and Sysmex has accelerated the deployment of automated and intelligent solutions to the clinical frontline, promising to activate a new model for high-quality development in clinical laboratories and providing substantial support to laboratory operations. In the future, we look forward to seeing automated solutions more widely applied in emergency laboratory testing.”